• Biobanking: A Thing Of The Past?

    Bio-IT World | Andrew Brooks, COO at RUCDR Infinite Biologics and Professor of Genetics at Rutgers University, discusses the changes he's seen in biobanking over the last decade, including the rapid changes direct to consumer applications are bringing to research biobanks, and whether or not traditional biobanks are a thing of the past.

    Jun 13, 2019

  • Golden Helix Releases Cancer Add-On To VSClinical

    Bio-IT World News Brief | Golden Helix has announced a cancer addition to their clinical analytics product, VSClinical. This new capability will guide clinicians through the clinical assessment of somatic variants, adding workflows modeled off the guidelines issued by the Association of Molecular Pathologists.

    Jun 10, 2019

  • Organoids And Their Impact On Pre-Clinical Drug Discovery

    Bio-IT World | Pharmaceutical companies are looking for ways to save time and money in the drug discovery process. If there was a way to determine a therapy's impact in the pre-clinical process, researchers would have a better understanding of where to focus their efforts. This is where organoids come in.

    Jun 7, 2019

  • The Future Of Blockchain: The Use Cases Set To Reshape Life Sciences

    Bio-IT World Contributed Commentary | Ever since blockchain burst onto the scene a decade ago, people have continually found new—and sometimes odd—applications for the technology. Yet when it comes to the life sciences, a lack of practical applications has resulted in blockchain being considered a "hammer in search of a nail."

    Jun 5, 2019

  • 2 Chinese Babies With Edited Genes May Face Higher Risk Of Premature Death

    NPR.org | There are new concerns about the world's first genetically modified babies. It appears that the genetic variation a Chinese scientist was trying to recreate when he edited twin girls' DNA may be more harmful than helpful to health overall, according to a study published Monday.

    Jun 3, 2019

  • PerkinElmer Joins Accenture's Open Partner Ecosystem

    Bio-IT World | PerkinElmer has signed on to Accenture's open partner ecosystem and will integrate its big data technology and content into the cloud-based platform's wider efforts in drug discovery and research.

    Jun 3, 2019

  • Grail Outlines Its Plans For A Blood Test To Detect Cancer

    STAT | Could a blood test detect cancer in healthy people? Grail, a Menlo Park, Calif.-based company, has raised $1.6 billion in venture capital to prove the answer is yes.

    May 31, 2019

  • ACD/Labs, Genomenon, Accenture, And More: News From May 2019

    Bio-IT World | May featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including ACD/Labs, Genomenon, Accenture, and more.

    May 30, 2019

  • MGI Sues Illumina for Patent Infringement in the United States

    Bio-IT World News Brief | Complete Genomics Inc., a US subsidiary of MGI, has filed a patent infringement lawsuit against Illumina in US District Court for the District of Delaware.

    May 29, 2019

  • Exploring The Species Near Us

    Bio-IT World | Rob Dunn, Professor of Applied Ecology, North Carolina State University has written an engaging and absorbing account of his adventures in ecology, starting with field work in the remote rain forests of Costa Rica. Eventually he learned he could discover closer to home—and help students identify—previously unknown bacteria and insects in houses, including those living in showerheads and extremophiles living in freezers and ovens.

    May 23, 2019

  • Adimab Team Accuses Prominent MIT Investigator Of Ripping Off Antibodies, Presenting Them As His Own

    Endpoints News | In an opinion paper published yesterday, John Carroll at Endpoints News speaks with Adimab chief Tillman Gerngross and MIT investigator Ram Sasisekharan about Gerngross's recent allegations against Sasisekharan, claiming he has been ripping off the work of others in the antibody field and passing it off as his own design done in silico.

    May 22, 2019

  • New Math Model Could Impact The Study Of Rapidly Evolving Diseases

    Bio-IT World | Researchers at Florida State University have developed a computational model with the potential to change the way researchers approach population genetics and the spread of diseases that evolve quickly in response to different environments.

    May 20, 2019

  • HPE Agrees to Buy Supercomputer Maker Cray for $1.4 Billion

    Bloomberg.com | Hewlett Packard Enterprise Co. has agreed to buy U.S. supercomputer maker Cray Inc. in a deal valued at about $1.4 billion as the firm works to become more competitive in high-end computing.

    May 17, 2019

  • A Bird's Eye View Of Data Consultancies

    Bio-IT World | During a panel discussion at the Bio-IT World Conference & Expo, three data science consultants came together to discuss the intricacies of the industry they so often work with.

    May 16, 2019

  • The Return On Investment Of Healthcare Compliance

    Bio-IT World Contributed Commentary | Healthcare companies, especially in growth phase, must be able to demonstrate the ability to comply with the laws that control their business and to identify fissures in operations quickly. Entrepreneurs and investors should therefore view compliance as a competitive advantage that puts the company in a favorable position to avoid—and swiftly and effectively to tackle—potential regulatory challenges.

    May 15, 2019

  • Medidata Launches Acorn AI For End-to-End Data Insights

    Bio-IT World | Medidata Solutions has launched Acorn AI, a Medidata company dedicated to making "data liquid across the end-to-end lifecycle of a pharmaceutical and life sciences company—from research all the way to development and into post-market."

    May 13, 2019

  • Bio-IT FAIR Data Hackathon 'Pushes The Needle' In Science

    Bio-IT World | The Bio-IT World Conference & Expo recently hosted the third annual Bio-IT FAIR Data Hackathon, giving experts in life sciences and IT the opportunity to FAIR-ify a range of existing data sets.

    May 13, 2019

  • GA4GH Launches ELIXIR Partnership, Diverse Driver Projects

    Bio-IT World  In February, the 20th European nation signed the European Declaration, an effort to sequence and provide transnational access to at least one million human genomes by 2022—putting to rest any lingering doubts about the breadth of our data sharing challenges and the importance of international standards. The Global Alliance for Genomics and Health is at the forefront of the work.  

    May 9, 2019

  • AI In Real-World Drug Discovery: The Experts Weigh In

    Bio-IT World | An "AI in Practice" keynote panel session at the recent Bio-IT World Congress & Expo in Boston discusses the efficiencies machine learning is creating in drug development, as well as the overall AI strategy companies are still formulating.

    May 8, 2019

  • Open Science Needs A Do-Over

    Bio-IT World | In his keynote presentation during opening ceremonies of the 18th Annual Bio-IT World Conference & Expo, John Wilbanks, chief commons officer of Merck spinoff Sage Bionetworks, explained how the business of research has traditionally focused on producing academic papers, limiting the growth of scientific knowledge to "massive incrementalism" around a succession of magic-bullet solutions—microassays, human genome project, robotics and artificial intelligence and, most recently, open science.

    May 6, 2019